7 October 2021: Interview Börsenradio with Dr. Jan Schmidt-Brand, CEO
Schritt von einem reinen Forschungsunternehmen zu einem Entwicklungsunternehmen (in German only)
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.